Joshua E. Meyer, MD
- Request Appointment
- Clinical Locations
- About
- Education and Training
- Patient Stories
- Research Profile
- Publications
- Ratings
Clinical Locations
Primary Location
Fox Chase Cancer Center
333 Cottman Avenue
Philadelphia, PA 19111
Vice Chair, Translational Research, Department of Radiation Oncology
Associate Professor, Department of Radiation Oncology
Specialties
Treatment Focus
Stereotactic Body Radiation Therapy (SBRT), Intensity Modulated Radiation Therapy (IMRT), Image-Guided Radiation Therapy (IGRT), Radioembolization, MR-guided Focused Ultrasound, Re-irradiation, Pulsed Low Dose Rate (PLDR) radiation, Brachytherapy, Anal Cancer
Research Program
Treatment Philosophy
As technologies and treatments continue to advance, there are more and more options in the details of how each cancer patient is treated. I work with my colleagues in other disciplines to define the most appropriate treatment for each individual patient. For each individual I am treating with radiation, I make a concerted effort to survey the landscape of potential treatment choices that I am able to bring to a particular patient’s care to ensure that the most effective, precise and targeted approach is being used in every situation. This allows patients to get the maximum amount of benefit from treatment with as small a risk of complications as possible.
Educational Background
- Resident, Stich Radiation Center, Weill Cornell Medical Center, New York, NY
- MD, University of Massachusetts Medical School, Worcester, MA, 2005
- BA, Haverford College, Haverford, PA, 1998
Certifications
- Board Certified, Radiation Oncology, American College of Radiology, 2011
Memberships
- American College of Radiology (ACR)
- American Society of Clinical Oncology (ASCO)
- American Society of Therapeutic Radiation Oncology (ASTRO)
Honors & Awards
- ARRO Educator of the Year, 2015
- Clinical Fellow, ASCO/AACR Workshop on Methods in Clinical Cancer Research, 2009
- Roentgen Resident/Fellow Research Award, 2009
- Lang Research Award, New York Hospital of Queens Residents and Fellows Day, 2009
- American Radium Society Travel Grant, 2009
- ASCO Cancer Foundation Merit Award, American Society of Clinical Oncology, 2009
- International Society of Gastrointestinal Oncology Conference Educational Grant, 2008
Rodney Malarchik
Rodney Malarchik
[Treatment] is worthwhile because once you are on the other side, you have a promise of a future. That is impactful. You need to find a path through it if you can.
Anthony Demidio
Anthony Demidio
I’m 62 and I live in Bristol, Pa., with my wife Maryann. Between the two of us, we have four children and eight grandchildren (with another on the way). I also have a large extended family, and I work full time as a contractor. Needless to say, I’m a pretty busy guy!
Nick Pifani
Nick Pifani
I’m 45 and live in Delran, New Jersey, with my wife and two kids. I work as a vice president of business development for MasterCard, and in my spare time I love to run.
I’ve run marathons and completed an Ironman 70.3 (also known as a Half Ironman), which consists of a 1.2-mile swim, a 56-mile bike ride, and a 13.1-mile run. So, I’m no stranger to pain and discomfort.
Alan Zlatkin
Alan Zlatkin
Being defeated is a matter of perspective and will. I feel that no matter how serious the illness is, I can overcome it with the right help and the right attitude.
Andre Burke
Andre Burke
I often share my story and always encourage people who feel something is wrong to go to the doctor to get checked out. If you wait too long, it may be too late. I am thankful that I took that advice.
Pages
Research Program
Research Interests
My interests are in clinical research for gastrointestinal cancers. This includes the new application of radiation technology to increase surgical resectability and cure rates. It also includes outcomes work to determine which management strategies are the most effective for these patients.
Selected Publications
LS Wang, T Shaikh, EA Handorf, JP Hoffman, SJ Cohen, JE Meyer. Dose Escalation With a Vessel Boost in Borderline Resectable Pancreatic Adenocarcinoma Treated With Neoadjuvant Chemoradiation. Practical Radiation Oncology 90(1); 2015. PubMed
Shaikh T, Ruth K, Scoot WJ, Burtness BA, Cohen SJ, Konski AA, Cooper HS, Astsaturov I, Meyer JE. “Increased time from neoadjuvant chemoradiation to surgery is associated with higher pathologic complete response rates in esophageal cancer.” Ann Thorac Surg, 99(1):270-6, 2015 PubMed
Meyer JE, Panico VJ, Marconato HM, Sherr DL, Christos P, Pirog EC. “HIV positivity but not HPV/p16 status is associated with higher recurrence rate in anal cancer.” J Gastrointest Cancer, 44(4):450-5; 2013. PubMed
Meyer JE, Cohen SJ. “Beyond First-Line Therapy: Combining Chemotherapy and Radioembolization for Hepatic Colorectal Metastases.” J Nucl Med Radiat Ther 2:1-6; 2011
Meyer JE, Sherr DL. “Reply to receptive anal intercourse as a potential risk factor for rectal cancer.” Cancer. 117:3284-5; 2011.
Meyer JE, Narang T, Schnoll-Sussman FH, Pochapin MB, Christos PJ, Sherr DL. “Increasing incidence of rectal cancer in patients aged younger than 40 years.” Cancer. 116:4354-9; 2010. PubMed
Meyer JE, Sherr DL. “When Less Is More, When Less Is Less: Local Excision in Early Rectal Cancer.” Gastrointest Cancer Res. 3(3): 123-4; 2009. PubMed
Fitzgerald TJ, Simon E, Meyer JE. “Prostate carcinoma: opportunities for translational research” J Cell Biochem 91(3):433-42, 2004. PubMed
Additional Publications
Clinical Locations
Primary Location
Fox Chase Cancer Center
333 Cottman Avenue
Philadelphia, PA 19111
Vice Chair, Translational Research, Department of Radiation Oncology
Associate Professor, Department of Radiation Oncology
Treatment Focus
Stereotactic Body Radiation Therapy (SBRT), Intensity Modulated Radiation Therapy (IMRT), Image-Guided Radiation Therapy (IGRT), Radioembolization, MR-guided Focused Ultrasound, Re-irradiation, Pulsed Low Dose Rate (PLDR) radiation, Brachytherapy, Anal Cancer
Research Program
Treatment Philosophy
As technologies and treatments continue to advance, there are more and more options in the details of how each cancer patient is treated. I work with my colleagues in other disciplines to define the most appropriate treatment for each individual patient. For each individual I am treating with radiation, I make a concerted effort to survey the landscape of potential treatment choices that I am able to bring to a particular patient’s care to ensure that the most effective, precise and targeted approach is being used in every situation. This allows patients to get the maximum amount of benefit from treatment with as small a risk of complications as possible.
Education
Educational Background
- Resident, Stich Radiation Center, Weill Cornell Medical Center, New York, NY
- MD, University of Massachusetts Medical School, Worcester, MA, 2005
- BA, Haverford College, Haverford, PA, 1998
Certifications
- Board Certified, Radiation Oncology, American College of Radiology, 2011
Memberships
- American College of Radiology (ACR)
- American Society of Clinical Oncology (ASCO)
- American Society of Therapeutic Radiation Oncology (ASTRO)
Honors & Awards
- ARRO Educator of the Year, 2015
- Clinical Fellow, ASCO/AACR Workshop on Methods in Clinical Cancer Research, 2009
- Roentgen Resident/Fellow Research Award, 2009
- Lang Research Award, New York Hospital of Queens Residents and Fellows Day, 2009
- American Radium Society Travel Grant, 2009
- ASCO Cancer Foundation Merit Award, American Society of Clinical Oncology, 2009
- International Society of Gastrointestinal Oncology Conference Educational Grant, 2008
Research Profile
Research Interests
My interests are in clinical research for gastrointestinal cancers. This includes the new application of radiation technology to increase surgical resectability and cure rates. It also includes outcomes work to determine which management strategies are the most effective for these patients.
Publications
Selected Publications
LS Wang, T Shaikh, EA Handorf, JP Hoffman, SJ Cohen, JE Meyer. Dose Escalation With a Vessel Boost in Borderline Resectable Pancreatic Adenocarcinoma Treated With Neoadjuvant Chemoradiation. Practical Radiation Oncology 90(1); 2015. PubMed
Shaikh T, Ruth K, Scoot WJ, Burtness BA, Cohen SJ, Konski AA, Cooper HS, Astsaturov I, Meyer JE. “Increased time from neoadjuvant chemoradiation to surgery is associated with higher pathologic complete response rates in esophageal cancer.” Ann Thorac Surg, 99(1):270-6, 2015 PubMed
Meyer JE, Panico VJ, Marconato HM, Sherr DL, Christos P, Pirog EC. “HIV positivity but not HPV/p16 status is associated with higher recurrence rate in anal cancer.” J Gastrointest Cancer, 44(4):450-5; 2013. PubMed
Meyer JE, Cohen SJ. “Beyond First-Line Therapy: Combining Chemotherapy and Radioembolization for Hepatic Colorectal Metastases.” J Nucl Med Radiat Ther 2:1-6; 2011
Meyer JE, Sherr DL. “Reply to receptive anal intercourse as a potential risk factor for rectal cancer.” Cancer. 117:3284-5; 2011.
Meyer JE, Narang T, Schnoll-Sussman FH, Pochapin MB, Christos PJ, Sherr DL. “Increasing incidence of rectal cancer in patients aged younger than 40 years.” Cancer. 116:4354-9; 2010. PubMed
Meyer JE, Sherr DL. “When Less Is More, When Less Is Less: Local Excision in Early Rectal Cancer.” Gastrointest Cancer Res. 3(3): 123-4; 2009. PubMed
Fitzgerald TJ, Simon E, Meyer JE. “Prostate carcinoma: opportunities for translational research” J Cell Biochem 91(3):433-42, 2004. PubMed
Additional Publications
Related Articles
4 PATIENT COMMENTS
-
5.0
June 01, 2021
Very happy with my care and attention so far.
-
5.0
January 05, 2021
Dr. Meyer and nurse [...] represent without a doubt, the gold standard inpatient care. They are my heroes!
-
5.0
December 28, 2020
Dr. and assistance were very helpful & polite.
-
5.0
September 09, 2020
I can't imagine having anyone but Dr. Meyer and [...] take care of me. They are knowledgeable and very compassionate.
LOAD MORE